WASHINGTON, D.C. — The Food and Drug Administration (FDA) has issued a safety alert advising consumers not to use OPMS Black Liquid Kratom. This product, sold online and in some retail stores, has been linked to serious health risks, including death.
The alert specifically targets consumers who have recently purchased OPMS Black Liquid Kratom. The FDA urges these individuals to discontinue use immediately.
Health Risks
The FDA’s warning follows a report of a recent death associated with the use of OPMS Black Liquid Kratom. Other adverse effects reported include withdrawal symptoms, addiction, digestive issues, restless leg syndrome, skin problems, aggressive behavior, increased anxiety, lack of energy, and inability to focus.
The product label lists kratom alkaloids, mitragynine, and 7-hydroxymitragynine (7-OH mitragynine) as its active ingredients. These compounds have not been approved by the FDA for any therapeutic use.
Scope of the Problem
Kratom products like OPMS Black Liquid Kratom have been marketed as dietary supplements and even as drugs with claimed therapeutic benefits. However, the FDA has not approved any drugs containing kratom or its associated compounds. The agency has serious safety concerns about the use of kratom in dietary supplements and conventional foods.
FDA’s Position
The FDA maintains that kratom is not lawfully marketed as a dietary supplement and cannot be added to conventional foods. The agency emphasizes the risks of serious adverse events, including liver toxicity, seizures, and substance use disorder.
The FDA continues to monitor products containing kratom and urges consumers to avoid them due to significant health risks. As more information becomes available, the FDA will update the public to ensure consumer safety.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.